SCOPUS 정보 검색 플랫폼

Volumn 21, Issue 2, 2001, Pages 140-144

Treatment of migraine attacks with intranasal alniditan: An open study

(20) Diener, Hans Christoph a,b Louis, P b,b Schellens, R b De Beukelaar, F b,b Bourgeois, P b D'Hooghe, b Dehaene, b Fosselle, E b Geens, K b Meersman, G b Monte, b Schoenen, J b Tack, P b Vakaet, A b Van Buggenhout, E b Van Ussel, M b Limmroth, V b Gendolla, A b Foh M b Gobel H b

a UNIVERSITY HOSPITAL ESSEN (Germany)

b NONE

Author keywords

5 HT agonist; Alniditan; Intranasal application; Migraine

Indexed keywords

ALNIDITAN;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PHASE 2 CLINICAL TRIAL; TASTE DISORDER; THROAT DISEASE;

EID: 0034987728 PISSN: 03331024 EISSN: None Source Type: Journal
DOI: 10.1046/j.1468-2982.2001.00182.x Document Type: Article

Times cited : (3)

References (19)

1
- 85144134768
- R091274
- 1
- (1993) Janssen Research Foundation Investigator's Brochure. 2nd edn.

2
- 0028823452
- The discovery of a series of new non-indole 5-HT1D agonists
- 1
- (1995) Bioorg Med Chem Lett , vol.5 , pp. 2649-2654
- Van Lommen, G.¹ De Bruyn, M.² Schroven, M.³ Verschveren, W.⁴ Janssens, W.⁵ Verrelst, J.⁶ Leysen, J.E.⁷

3
- 0031953613
- 1D receptors expressed in various mammalian cell lines
- 1
- (1998) Br J Pharmacol , vol.123 , pp. 1655-1665
- Lesage, A.S.¹ Wouters, R.² Van Gompel, P.³ Heylen, L.⁴

4
- 0030447893
- 3H]alniditan
- 1
- (1996) Mol Pharmacol , vol.50 , pp. 1567-1580
- Leysen, J.E.¹ Gommeren, W.² Heylen, L.³ Luyten, W.H.M.L.⁴ Van de Weyer, I.⁵ Vanhoenacker, P.⁶

5
- 0032828090
- Effects of Alniditan (R 91746) on neurogenic edema in the rat dura mater and contraction of rat basilar artery
- 1
- (1999) Eur J Pharmacol , vol.382 , pp. 103-109
- Limmroth, V.¹ Bischof, A.² Fetscher, C.³ Wermelskirchen, D.⁴ Diener, H.C.⁵ Michel, M.⁶

6
- 0030003463
- Selective vasoconstriction by alniditan in the carotid vascular bed of anaesthetized dogs
- 1
- (1996) Eur J Pharmacol , vol.299 , pp. 127-137
- Van der Water, A.¹ D'Aubioul, J.² Van Gerven, W.³ Van Ammel, K.⁴ De Clerck, F.⁵

7
- 0000566185
- A placebo-controlled, dose-defining study of sumatriptan nasal spray in the acute treatment of migraine
- 1
- (1995) Cephalalgia , vol.15 , Issue.SUPPL. 14 , pp. 271-276
- Becker, W.J.¹

8
- 0030981544
- Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses
- 1
- (1997) Cephalalgia , vol.17 , pp. 541-550
- Moore, K.H.P.¹ Hussey, E.K.² Shaw, S.³ Fuseau, E.⁴ Duquesnoy, C.⁵ Pakes, G.E.⁶

9
- 0030667119
- Sumatriptan nasal spray for the acute treatment of migraine
- 1
- (1997) Neurology , vol.49 , pp. 1225-1230
- Ryan, R.¹ Elkind, A.² Baker, C.C.³ Mullican, W.⁴ DeBussy, S.⁵ Asgharnejad, M.⁶

10
- 0032067764
- Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine
- 1
- (1998) Arch Family Med , vol.7 , pp. 234-240
- Diamond, S.¹ Elkind, A.² Jackson, R.T.³ Ryan, R.⁴ DeBussey, S.⁵ Asgharnejad, M.⁶

11
- 0031857924
- Consistency of response to sumatriptan nasal spray across patient sub-groups and migraine types
- 1
- (1998) Cephalalgia , vol.18 , pp. 273-277
- Ashford, E.¹ Salonen, R.² Saiers, J.³ Woessner, M.⁴

13
- 85144145093
- Tolerability, cardiovascular and laboratory safety and pharmacokinetics of increasing single subcutaneous doses of 0.6, 0.8 and 1 mg of R91274 in healthy volunteers. Part II
- Janssen Research Foundation. Clinical Research Report on R91274 ALN-BEL-7, October. N99995
- 1
- (1993) Pharmacokinetics
- Van Peer, A.¹ Woestenborghs, R.² Heykants, J.³ Crabbé, R.⁴ De Beukelaar, F.⁵

14
- 85144123575
- Evaluation of the safety, tolerability and pharmacokinetics of two subcutaneous injections of 1 mg of R091274 given with an interval of 1 hour in healthy subjects. Part II
- Clinical Research Report on R91274 ALN-BEL-23, November. N114440
- 1
- (1995) Pharmacokinetics
- Soons, P.A.¹ Van Bortel, L.² De Beukelaar, F.³ Woestenborghs, R.⁴ Van Peer, A.⁵

15
- 85144097197
- Evaluation of the pharmacokinetics, tolerability and safety of an intranasal administration of R091274 in 2 nostrils as an aqueous and a chitosan solution and as a starch microsphere formulation in 12 healthy subjects. Part II
- Janssen Research Foundation, June. Clinical Research Report R091274-BEL-31
- 1
- (1996) Pharmacokinetics
- Soons, P.A.¹ Crabbe, R.² De Beukelaar, F.³ Woestenborghs, R.⁴ Van Peer, A.⁵

16
- 85144128121
- Janssen Research Foundation, June. Clinical Research Report R091274-BEL-36
- 1
- (1996) Evaluation of the tolerability, safety and pharmacokinetics of 2 and 4 mg of intranasal alniditan given twice with an interval of 2 hours in 12 healty volunteers
- Soons, P.A.¹ Van Borel, L.² De Beukelaar, F.³ Woestenborghs, R.⁴ Van Peer, A.⁵

17
- 0029839252
- Alniditan in the acute treatment of migraine attacks: A subcutaneous dose-finding study
- 1
- (1996) Cephalalgia , vol.16 , pp. 497-502
- Goldstein, J.¹ Dahlöf, C.G.H.² Diener, H.C.³ Olesen, J.⁴ Schellens, R.⁵ Senard, J.M.⁶

18
- 0346031709
- Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
- 1
- (1988) Cephalalgia , vol.8 , Issue.SUPPL. 7 , pp. 9-96

19
- 0020108590
- One sample procedure for phase II clinical trials
- 1
- (1982) Biometrics , vol.38 , pp. 143-151
- Thomas, R.¹ Fleming, F.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.